Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
24.94
-0.16 (-0.64%)
At close: Nov 20, 2024, 4:00 PM
24.84
-0.10 (-0.40%)
Pre-market: Nov 21, 2024, 5:47 AM EST
Pfizer Market Cap
Pfizer has a market cap or net worth of $141.33 billion as of November 21, 2024. Its market cap has decreased by -19.71% in one year.
Market Cap
141.33B
Enterprise Value
204.37B
1-Year Change
-19.71%
Ranking
Category
Stock Price
$24.94
Market Cap Chart
Since December 1, 1998, Pfizer's market cap has decreased from $144.06B to $141.33B, a decrease of -1.89%. That is a compound annual growth rate of -0.07%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 19, 2024 | 142.24B | -12.50% |
Dec 29, 2023 | 162.56B | -43.48% |
Dec 30, 2022 | 287.63B | -13.22% |
Dec 31, 2021 | 331.44B | 61.99% |
Dec 31, 2020 | 204.60B | -5.64% |
Dec 31, 2019 | 216.83B | -14.07% |
Dec 31, 2018 | 252.32B | 16.87% |
Dec 29, 2017 | 215.90B | 9.54% |
Dec 30, 2016 | 197.10B | -1.09% |
Dec 31, 2015 | 199.26B | 1.53% |
Dec 31, 2014 | 196.27B | -1.13% |
Dec 31, 2013 | 198.52B | 7.51% |
Dec 31, 2012 | 184.65B | 11.00% |
Dec 30, 2011 | 166.35B | 18.60% |
Dec 31, 2010 | 140.25B | -4.45% |
Dec 31, 2009 | 146.78B | 22.92% |
Dec 31, 2008 | 119.42B | -23.08% |
Dec 31, 2007 | 155.24B | -16.87% |
Dec 29, 2006 | 186.75B | 8.64% |
Dec 30, 2005 | 171.90B | -15.11% |
Dec 31, 2004 | 202.51B | -24.89% |
Dec 31, 2003 | 269.62B | 43.13% |
Dec 31, 2002 | 188.38B | -24.81% |
Dec 31, 2001 | 250.53B | -13.68% |
Dec 29, 2000 | 290.22B | 131.09% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Thermo Fisher | 191.74B |
Intuitive Surgical | 189.36B |
Danaher | 166.17B |
Amgen | 149.84B |
Stryker | 148.45B |
Boston Scientific | 133.31B |
Sanofi | 121.20B |
Vertex Pharmaceuticals | 120.27B |